CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...
ATB Capital Markets lowered its 12 month target price on AutoCanada to C$25 from C$30 after reviewing the company’s ...
In a report released today, Ty Collin from CIBC maintained a Buy rating on AutoCanada, with a price target of C$33.00. Collin covers the Consumer Cyclical sector, focusing on stocks such as Magna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback